Results 341 to 350 of about 95,723 (355)
Some of the next articles are maybe not open access.
Ocular toxoplasmosis II: clinical features, pathology and management
Clinical and Experimental Ophthalmology, 2013João M Furtado, Justine R Smith
exaly
The Challenges and Promise of Complement Therapeutics for Ocular Diseases
Frontiers in Immunology, 2019Dong Ho Park+2 more
exaly
Advanced drug delivery and targeting technologies for the ocular diseases
BioImpacts, 2016Yadollah Omidi+2 more
exaly
Fundamentals, challenges, and nanomedicine‐based solutions for ocular diseases
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2019Dadi A Srinivasarao, Dhirendra S Katti
exaly
Understanding, recognizing, and managing toxicities of targeted anticancer therapies
Ca-A Cancer Journal for Clinicians, 2013exaly
Ocular blood flow in glaucoma – the Leuven Eye Study
Acta Ophthalmologica, 2016Abraham Shibesh+2 more
exaly
Cancer Excision from Eyelids and Ocular Adnexa: The Mohs Fresh Tissue Technique and Reconstruction
Ca-A Cancer Journal for Clinicians, 1982exaly
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Nature Reviews Drug Discovery, 2006exaly